
PDXen Biosystem Inc. is a cutting-edge biotechnology company focused on personalized and proactive healthcare solutions. They specialize in early disease detection and tailored treatments, particularly for cancer and dementia. Their core offerings include advanced organoid models, real-time cell tracking for precision cancer treatment, and non-invasive biomarker detection systems for early dementia prevention. PDXen leverages multimodal data, machine learning, and AI-powered monitoring to provide data-driven diagnostics and continuous health monitoring, aiming to improve patient outcomes, reduce side effects, and lower healthcare costs.

PDXen Biosystem Inc. is a cutting-edge biotechnology company focused on personalized and proactive healthcare solutions. They specialize in early disease detection and tailored treatments, particularly for cancer and dementia. Their core offerings include advanced organoid models, real-time cell tracking for precision cancer treatment, and non-invasive biomarker detection systems for early dementia prevention. PDXen leverages multimodal data, machine learning, and AI-powered monitoring to provide data-driven diagnostics and continuous health monitoring, aiming to improve patient outcomes, reduce side effects, and lower healthcare costs.